Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1995
03/14/1995US5397591 Infant formula and baby food containing docosahexaenoic acid obtained from dinoflagellates
03/14/1995US5397576 Spray triturated micronutrient compositions
03/14/1995CA2131760A1 Nucleic acid-binding oligomers possessing c-branching for therapy and diagnostics
03/14/1995CA2131755A1 Nucleic acid-binding oligomers possessing n-branching for therapy and diagnostics
03/14/1995CA2106015A1 Ribozymes having 2'-0 substituted nucleotides in the flanking sequences
03/14/1995CA2029047C Sustained release compositions for treating periodontal disease
03/14/1995CA1334761C Benzylamine derivatives, process for production thereof, and use thereof
03/14/1995CA1334760C N-(2'-aminophenyl)-benzamide-derivatives, process for their preparation and their use in the control of neoplastic diseases
03/14/1995CA1334759C N,n'-diaminocarbonylmethyl-n,n'-dicarboxymethyl-1,2- diaminoethane derivatives
03/14/1995CA1334757C Rhizoxin derivatives and their use as anti-tumor agents
03/14/1995CA1334756C 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
03/14/1995CA1334755C Benzopyranopyridineacetic acid ester compounds and their pharmaceutical uses
03/14/1995CA1334754C 5-aryl-substituted-2,3-dihydro-imidazo¬1,2-a|furo and -thieno pyridines
03/14/1995CA1334753C Glycerin derivative and its pharmacological use
03/14/1995CA1334752C Drug effect-enhancing agent for antitumor drug
03/14/1995CA1334751C Ureylene-2,4,6-pyrimidine-3-oxide derivatives, their preparation and use in cosmetics and dermopharmacy
03/14/1995CA1334738C Methods and compositions for the treatment of niddm
03/11/1995CA2129509A1 Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis
03/10/1995CA2131648A1 Process of making a benzothiadiazole derivative
03/10/1995CA2131569A1 Formulation comprising antibacterial substance and antiulcer substance
03/10/1995CA2131487A1 Cessation of tobacco use
03/09/1995WO1995006754A1 Methods for screening antiestrogen compounds
03/09/1995WO1995006688A1 Phthalocyanine photosensitizers for photodynamic therapy and methods for their synthesis and use
03/09/1995WO1995006666A1 Anti-gp39 antibodies and uses therefor
03/09/1995WO1995006647A1 ALKOXY-SUBSTITUTED β-CARBOLINES ACTING ON THE AMPA-RECEPTOR
03/09/1995WO1995006645A1 Benzofuran derivatives as tachykinin antagonists
03/09/1995WO1995006640A1 Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
03/09/1995WO1995006638A1 Tryptamine analogs with 5-ht1d selectivity
03/09/1995WO1995006637A1 Indole and indoline derivatives as 5ht1d receptor antagonists
03/09/1995WO1995006636A1 5-arylindole derivatives
03/09/1995WO1995006634A1 New 9-chloro-prostaglandin derivatives
03/09/1995WO1995006628A1 Treatment and prophylaxis of diseases caused by parasites or bacteria
03/09/1995WO1995006486A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995WO1995006482A1 1α,24-(OH)2-VITAMIN D3 EMULSION COMPOSITION
03/09/1995WO1995006481A1 Methods for inducing antigen-specific t cell tolerance
03/09/1995WO1995006476A1 Methods and compositions for treating neoplastic disorders
03/09/1995WO1995006473A2 Medical use of polysulfonic acid compound
03/09/1995WO1995006472A1 Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process
03/09/1995WO1995006471A1 Blood triglyceride lowering agent
03/09/1995WO1995006470A1 Prevention and treatment of alzheimer's disease
03/09/1995WO1995006469A1 Benzazole compounds for use in therapy
03/09/1995WO1995006468A1 Method for treating migraine headaches
03/09/1995WO1995006467A1 Treatment of laminitis
03/09/1995WO1995006466A1 Treatment of anorectal disorders
03/09/1995WO1995006465A1 Thiol compounds for strengthening the immune system and immune reactions
03/09/1995WO1995006464A1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa
03/09/1995WO1995006461A1 Stabilized tablet formulation
03/09/1995WO1995006457A1 Compositions against skin impurities and mild forms of acne containing lanolinic acid or lanolinic acid components as active substance
03/09/1995WO1995006410A1 Treatment of chronic inflammatory diseases by angiotension ii receptor antagonists
03/09/1995WO1995002613A3 Heparin derivatives having antimetastatic activity
03/09/1995WO1995002603A3 Use of cephem derivatives as anti-metastatic agents
03/09/1995WO1995001791A3 Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
03/09/1995WO1995001782A3 Method for making freeze dried drug dosage forms
03/09/1995WO1995001348A3 Imides as inhibitors of tnp alpha
03/09/1995DE4330234A1 The use of progestogens and competitive progesterone antagonists for the production of pharmaceuticals for female fertility control and compositions comprising a progestogen and a competitive progesterone antagonist
03/09/1995DE4330105A1 Use of ss-hetaryl-ss-oxopropionitriles as pesticides
03/09/1995DE4326698A1 Use of a combination of folic acid, vitamin B6 and vitamin B12 for the prophylaxis and therapy of arteriosclerosis
03/09/1995DE3590020C2 1-Hydroxy-vitamin-D compounds which are unsaturated in the side chain
03/09/1995CA2170974A1 Phthalocyanine photosensitizers for photodynamic therapy and methods for their synthesis and use
03/09/1995CA2170892A1 Stabilized tablet formulation
03/09/1995CA2170615A1 Alkoxy-substituted .beta.-carbolines acting on the ampa-receptor
03/09/1995CA2170613A1 New 9-chloro-prostaglandin derivatives
03/09/1995CA2170508A1 Benzazole compounds for use in therapy
03/09/1995CA2170349A1 Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppresive agents
03/09/1995CA2169557A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995CA2169466A1 Methods for screening antiestrogen compounds
03/09/1995CA2148373A1 Delta 5-androstenes useful for promoting weight maintenance or weight loss and treatment process
03/09/1995CA2147991A1 Tryptamine analogs with 5-ht1d selectivity
03/09/1995CA2131512A1 Nutritional supplement
03/08/1995EP0641797A1 Cephem derivatives and antimicrobial agents containing the same
03/08/1995EP0641795A1 Carbapenem derivative
03/08/1995EP0641793A1 5-Amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
03/08/1995EP0641792A1 1,2-Dithiole derivatives and therapeutic agents containing them
03/08/1995EP0641791A1 Novel benzothiophene derivative
03/08/1995EP0641790A1 Tocopherols
03/08/1995EP0641787A1 2H-naphth[2,3-b]-1,4-oxazine derivatives, their preparation and their use as serotonin 1D (5-HT10) receptor agonists
03/08/1995EP0641785A1 Triazolylated tertiary amine compound or salt thereof
03/08/1995EP0641779A1 Novel 1-amidinopiperdines and 4-amidinomorpholines as aggregation inhibitions
03/08/1995EP0641770A1 Novel compound with platelet aggregation inhibitor activity
03/08/1995EP0641769A1 Amino acid derivative
03/08/1995EP0641768A1 Nitroxyalkylamide derivative
03/08/1995EP0641767A1 Cytotoxic stilbene derivatives and pharmaceutical composition containing them
03/08/1995EP0641766A1 Alkoxyphenylalkylamine derivative
03/08/1995EP0641760A1 Phenylalkanoic acid derivative, production thereof, and separation of optical isomers thereof
03/08/1995EP0641759A1 Aromatic carboxylic acid derivatives, their preparation and drugs containing these derivatives
03/08/1995EP0641569A1 Antipruritic
03/08/1995EP0641566A1 Methods of inhibiting vascular restenosis
03/08/1995EP0641565A1 Contraceptive and menstrual cycle controlling drug having oncostatic properties
03/08/1995EP0641563A1 Remedy for cataract and production thereof
03/08/1995EP0641562A1 Nutritional supplement
03/08/1995EP0641356A1 Inhibitors of 5-alpha-testosterone reductase
03/08/1995EP0641355A1 Steroid sulphatase inhibitors
03/08/1995EP0641345A1 Hypoglycemic n-sulfonyl-tetrahydro- 1,3]-dioxepino 5,6-b]azirines
03/08/1995EP0641344A1 8-substituted anthines as phosphodiesterase inhibitors
03/08/1995EP0641343A1 4-mercaptoacetylamino- 2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
03/08/1995EP0641342A1 Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines
03/08/1995EP0641341A1 METHOD FOR PREPARING BENZO b]NAPHTHYRIDINES
03/08/1995EP0641340A1 NEW 3-(SUBSTITUTED TETRAZOLYL)-4-OXO-4H-PYRIDO- 1,2-a]PYRIMIDINES, SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME
03/08/1995EP0641339A1 Azaspiro quinolone antibacterial agents
03/08/1995EP0641338A1 Hypoglycemic thiazolidinediones and intermediates
1 ... 7036 7037 7038 7039 7040 7041 7042 7043 7044 7045 7046 7047 7048 7049 7050 7051 7052 7053 7054 7055 7056 ... 7860